AI brief of an SEC Form 8-K · Envista (NVST)

Envista Q4 2024 sales rise 1.1% to $652.9 million; adjusted EPS falls to $0.24

Mixed Impact 4 of 5 earnings Written later

Envista reported fourth-quarter 2024 sales of $652.9 million, up 1.1% from a year earlier, and GAAP net income of $1.2 million, compared with a loss of $217.4 million in the same quarter of 2023. Adjusted diluted EPS fell to $0.24 from $0.29, and adjusted EBITDA declined to $91.0 million, so headline profit measures moved in different directions. The company also issued full-year 2025 guidance and reported a full-year 2024 net loss of $1,118.6 million, driven by a $1,153.8 million goodwill and intangible asset impairment.

Key points

  • Q4 2024 sales were $652.9 million, with core sales up 2.0%; GAAP diluted EPS was $0.01 versus a loss of $1.27 a year earlier
  • Q4 2024 adjusted EBITDA was $91.0 million, down from $100.5 million, with a margin of 13.9% versus 15.6%
  • Full-year 2024 net loss was $1,118.6 million, including a $1,153.8 million goodwill and intangible asset impairment
  • 2025 guidance calls for core sales growth of 1% to 3%, adjusted EBITDA margin of about 14%, and adjusted EPS of $0.95 to $1.05, compared with full-year 2024 adjusted EPS of $0.73

The filing

CompanyEnvista (NVST)
Form8-K, current report
Filed with the SECFeb 5, 2025, 4:18 PM ET
Accession number0001757073-25-000005

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:01 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.